OpenProtein.AI

While the core concept of utilizing machine learning for protein engineering addresses a highly practical and actionable real-world problem, this specific submission appears to be low-effort or speculative. Claims such as an audience reach of 'everyone' and 'most people have used my product' are entirely unsubstantiated for a specialized biotech platform. The lack of verifiable user metrics, coupled with vague technical details, warrants a baseline quality multiplier of 0.5 across all criteria. Consequently, the project scores in the minimal traction tier.